MAPK1 and breast neoplasm: Primary tumors of ‘node‐positive’ patients display higher ERK activity than those from ‘node‐negative’ patients and survival analyses show that low ERK activity in primary tumors is associated to relapse‐free survival of patients [26], suggesting a positive correlation between ERK activity and the metastatic potential of breast tumor cells.